Role of autoimmunity in organ allograft rejection: A focus on immunity to type V collagen in the pathogenesis of lung transplant rejection

Tina L. Sumpter, David S. Wilkes

Research output: Contribution to journalReview article

69 Citations (Scopus)

Abstract

Lung transplantation is the only definitive treatment modality for many forms of end-stage lung disease. However, the lung is rejected more often than any other type of solid organ allograft due to chronic rejection known as bronchiolitis obliterans (BO). Indeed, BO is the primary reason why the 5- and 7-yr survival rates are worse for the lung than for any other transplanted organ. Alloimmunity to donor antigens is established as the primary mechanism that mediates rejection responses. However, newer immunosuppressive regimens designed to abrogate alloimmune activation have not improved survival. Therefore, these data suggest that other antigens, unrelated to donor transplantation antigens, are involved in rejection. Utilizing human and rodent studies of lung transplantation, our laboratory has documented that a native collagen, type V collagen [col(V)], is a target of the rejection response. Col(V) is highly conserved; therefore, these data indicate that transplant rejection involves both alloimmune and autoimmune responses. The role of col(V) in lung transplant rejection is described in this review article. In addition, the potential role of regulatory T cells that are crucial to modulating autoimmunity and alloimmunity is also discussed.

Original languageEnglish (US)
Pages (from-to)L1129-L1139
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume286
Issue number6 30-6
DOIs
StatePublished - Jun 1 2004

Fingerprint

Collagen Type V
Graft Rejection
Autoimmunity
Bronchiolitis Obliterans
Allografts
Immunity
Lung Transplantation
Lung
Antigens
Unrelated Donors
Histocompatibility Antigens
Regulatory T-Lymphocytes
Immunosuppressive Agents
Lung Diseases
Rodentia
Collagen
Survival
Therapeutics

Keywords

  • Bronchiolitis obliterans
  • Major histocompatibility complex
  • Regulatory T cell

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Cell Biology
  • Physiology

Cite this

Role of autoimmunity in organ allograft rejection : A focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. / Sumpter, Tina L.; Wilkes, David S.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 286, No. 6 30-6, 01.06.2004, p. L1129-L1139.

Research output: Contribution to journalReview article

@article{845cb33b38db4d2bb83d9ba8b1357a04,
title = "Role of autoimmunity in organ allograft rejection: A focus on immunity to type V collagen in the pathogenesis of lung transplant rejection",
abstract = "Lung transplantation is the only definitive treatment modality for many forms of end-stage lung disease. However, the lung is rejected more often than any other type of solid organ allograft due to chronic rejection known as bronchiolitis obliterans (BO). Indeed, BO is the primary reason why the 5- and 7-yr survival rates are worse for the lung than for any other transplanted organ. Alloimmunity to donor antigens is established as the primary mechanism that mediates rejection responses. However, newer immunosuppressive regimens designed to abrogate alloimmune activation have not improved survival. Therefore, these data suggest that other antigens, unrelated to donor transplantation antigens, are involved in rejection. Utilizing human and rodent studies of lung transplantation, our laboratory has documented that a native collagen, type V collagen [col(V)], is a target of the rejection response. Col(V) is highly conserved; therefore, these data indicate that transplant rejection involves both alloimmune and autoimmune responses. The role of col(V) in lung transplant rejection is described in this review article. In addition, the potential role of regulatory T cells that are crucial to modulating autoimmunity and alloimmunity is also discussed.",
keywords = "Bronchiolitis obliterans, Major histocompatibility complex, Regulatory T cell",
author = "Sumpter, {Tina L.} and Wilkes, {David S.}",
year = "2004",
month = "6",
day = "1",
doi = "10.1152/ajplung.00330.2003",
language = "English (US)",
volume = "286",
pages = "L1129--L1139",
journal = "American Journal of Physiology",
issn = "1040-0605",
publisher = "American Physiological Society",
number = "6 30-6",

}

TY - JOUR

T1 - Role of autoimmunity in organ allograft rejection

T2 - A focus on immunity to type V collagen in the pathogenesis of lung transplant rejection

AU - Sumpter, Tina L.

AU - Wilkes, David S.

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Lung transplantation is the only definitive treatment modality for many forms of end-stage lung disease. However, the lung is rejected more often than any other type of solid organ allograft due to chronic rejection known as bronchiolitis obliterans (BO). Indeed, BO is the primary reason why the 5- and 7-yr survival rates are worse for the lung than for any other transplanted organ. Alloimmunity to donor antigens is established as the primary mechanism that mediates rejection responses. However, newer immunosuppressive regimens designed to abrogate alloimmune activation have not improved survival. Therefore, these data suggest that other antigens, unrelated to donor transplantation antigens, are involved in rejection. Utilizing human and rodent studies of lung transplantation, our laboratory has documented that a native collagen, type V collagen [col(V)], is a target of the rejection response. Col(V) is highly conserved; therefore, these data indicate that transplant rejection involves both alloimmune and autoimmune responses. The role of col(V) in lung transplant rejection is described in this review article. In addition, the potential role of regulatory T cells that are crucial to modulating autoimmunity and alloimmunity is also discussed.

AB - Lung transplantation is the only definitive treatment modality for many forms of end-stage lung disease. However, the lung is rejected more often than any other type of solid organ allograft due to chronic rejection known as bronchiolitis obliterans (BO). Indeed, BO is the primary reason why the 5- and 7-yr survival rates are worse for the lung than for any other transplanted organ. Alloimmunity to donor antigens is established as the primary mechanism that mediates rejection responses. However, newer immunosuppressive regimens designed to abrogate alloimmune activation have not improved survival. Therefore, these data suggest that other antigens, unrelated to donor transplantation antigens, are involved in rejection. Utilizing human and rodent studies of lung transplantation, our laboratory has documented that a native collagen, type V collagen [col(V)], is a target of the rejection response. Col(V) is highly conserved; therefore, these data indicate that transplant rejection involves both alloimmune and autoimmune responses. The role of col(V) in lung transplant rejection is described in this review article. In addition, the potential role of regulatory T cells that are crucial to modulating autoimmunity and alloimmunity is also discussed.

KW - Bronchiolitis obliterans

KW - Major histocompatibility complex

KW - Regulatory T cell

UR - http://www.scopus.com/inward/record.url?scp=2442637819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442637819&partnerID=8YFLogxK

U2 - 10.1152/ajplung.00330.2003

DO - 10.1152/ajplung.00330.2003

M3 - Review article

C2 - 15136293

AN - SCOPUS:2442637819

VL - 286

SP - L1129-L1139

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 1040-0605

IS - 6 30-6

ER -